Physicians' Understanding of Consent Requirements for Phase I Clinical Trials in Cognitively Impaired or Highly Vulnerable Patients

Author: Farber N.  

Publisher: Taylor & Francis Ltd

ISSN: 0898-9621

Source: Accountability in Research: Policies and Quality Assurance, Vol.11, Iss.1, 2004-01, pp. : 63-78

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract